-
Mashup Score: 2
Learn about the remarkable response rate and complete response rate of Lenvosiltamab in multiple myeloma patients. Explore this potential paradigm shift in treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
Plenary Session interview now available: Dr Sundar Jagannath, MD @TischCancer presents #Linvoseltamab yields strong response in #RRMM First 55 seconds below, watch full interview here [5 questions]: https://t.co/Iv7idArXnh https://t.co/808UbCgYzf